Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
QL-335 by QLSF Biotherapeutics for Colorectal Cancer: Likelihood of Approval
QL-335 is under clinical development by QLSF Biotherapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...